ABIVAX (EPA:ABVX) | WebDisclosure

PRESS RELEASE

published on 04/22/2025 at 22:05, 1 month 8 days ago

Abivax annonce les modalités de son Assemblée Générale Annuelle alors que la Société se rapproche d’étapes clés créatrices de valeur en 2025
Abivax annonce les modalités de son Assemblée Générale Annuelle pour le 6 juin 2025 à Paris, alors que la Société se rapproche d'étapes clés en 2025

Biotechnologie Abivax Assemblée Générale Annuelle Phase 3 Mécanismes De Régulation
PRESS RELEASE

published on 04/22/2025 at 22:05, 1 month 8 days ago

Abivax annonce les modalités de son Assemblée Générale Annuelle alors que la Société se rapproche d’étapes clés créatrices de valeur en 2025
Abivax annonce les modalités de son Assemblée Générale Annuelle et se rapproche d'étapes clés créatrices de valeur en 2025. Essais cliniques ABTECT de phase 3 en progression

Abivax Étapes Clés Assemblée Générale Annuelle Phase 3 ABTECT
BRIEF

published on 04/22/2025 at 22:05, 1 month 8 days ago

Abivax welcomes Dr. Dominik Höchli to its Board of Directors

Board Of Directors Abivax Phase 3 Immunology Dominik Höchli
BRIEF

published on 04/22/2025 at 22:05, 1 month 8 days ago

Abivax accueille le Dr Dominik Höchli au sein de son Conseil d’administration

Abivax Conseil D'administration Phase 3 Immunologie Dominik Höchli
PRESS RELEASE

published on 04/22/2025 at 22:05, 1 month 8 days ago

Abivax Announces Annual General Meeting Details as Company Advances Toward Key 2025 Value-Driving Milestones
Abivax announces details of Annual General Meeting on June 6, 2025, in Paris as it progresses towards key 2025 milestones, including Phase 3 ABTECT trials

Annual General Meeting Abivax Clinical-stage Biotechnology Phase 3 ABTECT Trials 2025 Milestones
PRESS RELEASE

published on 04/22/2025 at 22:00, 1 month 8 days ago

Abivax annonce la nomination du Dr Dominik Höchli au sein de son Conseil d’administration
Abivax nomme le Dr Dominik Höchli au Conseil d’administration pour renforcer son expertise en immunologie avant la publication des données clés de l’étude de phase 3 dans la rectocolite hémorragique en 2025

Abivax Conseil D'administration Rectocolite Hémorragique Immunologie Dr Dominik Höchli
PRESS RELEASE

published on 04/22/2025 at 22:00, 1 month 8 days ago

Abivax annonce la nomination du Dr Dominik Höchli au sein de son Conseil d’administration
Abivax annonce la nomination du Dr Dominik Höchli au sein de son Conseil d'administration. Expert en immunologie, son arrivée renforce l'équipe à l'approche de la publication des données clés de l'étude de phase 3

Abivax Conseil D'administration Nomination Immunologie Données De Phase 3
PRESS RELEASE

published on 04/22/2025 at 22:00, 1 month 8 days ago

Abivax Announces Appointment of Dominik Höchli, MD to Board of Directors
Abivax appoints Dominik Höchli, MD to Board of Directors, bringing extensive immunology expertise ahead of key Phase 3 data readout in ulcerative colitis in Q3 2025

Board Of Directors Abivax Ulcerative Colitis Dominik Höchli Phase 3 Data Readout
BRIEF

published on 04/18/2025 at 18:05, 1 month 12 days ago

ABIVAX : Capital Social et Droits de Vote au 31 Mars 2025

Euronext Paris Droits De Vote Capital Social Actions Abivax
BRIEF

published on 04/18/2025 at 18:05, 1 month 12 days ago

ABIVAX: Share Capital and Voting Rights as of March 31, 2025

Euronext Paris Share Capital Voting Rights Actions Abivax

Published on 05/31/2025 at 06:16, 8 hours 57 minutes ago

Moderna Receives U.S. FDA Approval for COVID-19 Vaccine mNEXSPIKE
Published on 05/31/2025 at 03:30, 11 hours 43 minutes ago

Avant Brands Inc. Announces Voting Results From 2025 Annual General Meeting of Shareholders
Published on 05/31/2025 at 01:45, 13 hours 28 minutes ago

GLG Life Tech Corporation Reports 2025 First Quarter Financial Results
Published on 05/30/2025 at 23:10, 16 hours 3 minutes ago

CORRECTION: Nextech3D.ai Migrates MAP Dynamics to AWS, Enabling Scalable AI Architecture and Accelerated Deployment
Published on 05/30/2025 at 23:00, 16 hours 13 minutes ago

Battery X Metals Achieves Full Capacity Recovery on a Real-World Imbalanced Battery from the #2 Out-of-Warranty Electric Vehicle Model in the United States in Preliminary Trial

View all ACCESSWIRE

Published on 05/31/2025 at 14:50, 22 minutes ago

Turkiye Garanti Bankasi A.S.: Brokerage Houses Warrants Redemption Prices
Published on 05/31/2025 at 14:46, 27 minutes ago

Turkiye Garanti Bankasi A.S.: CMB Approval for Bond Issuance to Foreign Markets
Published on 05/31/2025 at 14:41, 32 minutes ago

Turkiye Garanti Bankasi A.S.: Announcement regarding Fitch Ratings
Published on 05/31/2025 at 09:15, 5 hours 58 minutes ago

Hong Kong-headquartered International Mediation Body Established
Published on 05/30/2025 at 21:22, 17 hours 51 minutes ago

CPI PROPERTY GROUP publishes financial results for the first quarter of 2025

View all EQS

Published on 05/30/2025 at 22:00, 17 hours 13 minutes ago

Information sur les comptes annuels
Published on 05/30/2025 at 22:00, 17 hours 13 minutes ago

Information on the Annual Financial Statements
Published on 05/30/2025 at 18:14, 20 hours 59 minutes ago

Emova Group - Rapport annuel de Durabilité 23/24
Published on 05/28/2025 at 23:00, 2 days 16 hours ago

Standstill Commitments to hold shares of the company
Published on 05/28/2025 at 23:00, 2 days 16 hours ago

Engagements collectifs de conservation de titres de la société

View all LES ECHOS COMFI WIRE

News